These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 32897857

  • 1. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
    Frye M, Stritt S, Ortsäter H, Hernandez Vasquez M, Kaakinen M, Vicente A, Wiseman J, Eklund L, Martínez-Torrecuadrada JL, Vestweber D, Mäkinen T.
    Elife; 2020 Sep 08; 9():. PubMed ID: 32897857
    [Abstract] [Full Text] [Related]

  • 2. EphrinB2-EphB4 signals regulate formation and maintenance of funnel-shaped valves in corneal lymphatic capillaries.
    Katsuta H, Fukushima Y, Maruyama K, Hirashima M, Nishida K, Nishikawa S, Uemura A.
    Invest Ophthalmol Vis Sci; 2013 Jun 12; 54(6):4102-8. PubMed ID: 23696610
    [Abstract] [Full Text] [Related]

  • 3. EphB4 forward signalling regulates lymphatic valve development.
    Zhang G, Brady J, Liang WC, Wu Y, Henkemeyer M, Yan M.
    Nat Commun; 2015 Apr 13; 6():6625. PubMed ID: 25865237
    [Abstract] [Full Text] [Related]

  • 4. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun 13; 298(6):G908-15. PubMed ID: 20338920
    [Abstract] [Full Text] [Related]

  • 5. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.
    J Cell Sci; 2003 Jun 15; 116(Pt 12):2461-70. PubMed ID: 12734395
    [Abstract] [Full Text] [Related]

  • 6. Dysregulation of the EphrinB2-EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients.
    Fehnel KP, Penn DL, Duggins-Warf M, Gruber M, Pineda S, Sesen J, Moses-Gardner A, Shah N, Driscoll J, Zurakowski D, Orbach DB, Smith ER.
    Exp Mol Med; 2020 Apr 15; 52(4):658-671. PubMed ID: 32286515
    [Abstract] [Full Text] [Related]

  • 7. EphrinB2 Activation Enhances Vascular Repair Mechanisms and Reduces Brain Swelling After Mild Cerebral Ischemia.
    Ghori A, Freimann FB, Nieminen-Kelhä M, Kremenetskaia I, Gertz K, Endres M, Vajkoczy P.
    Arterioscler Thromb Vasc Biol; 2017 May 15; 37(5):867-878. PubMed ID: 28254815
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun 15; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 12. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
    Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Lüthi U, Barberis A, Benjamin LE, Mäkinen T, Nobes CD, Adams RH.
    Nature; 2010 May 27; 465(7297):483-6. PubMed ID: 20445537
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
    Diehl S, Bruno R, Wilkinson GA, Loose DA, Wilting J, Schweigerer L, Klein R.
    Pediatr Res; 2005 Apr 27; 57(4):537-44. PubMed ID: 15718372
    [Abstract] [Full Text] [Related]

  • 17. Endothelial EphB4 maintains vascular integrity and transport function in adult heart.
    Luxán G, Stewen J, Díaz N, Kato K, Maney SK, Aravamudhan A, Berkenfeld F, Nagelmann N, Drexler HC, Zeuschner D, Faber C, Schillers H, Hermann S, Wiseman J, Vaquerizas JM, Pitulescu ME, Adams RH.
    Elife; 2019 Nov 29; 8():. PubMed ID: 31782728
    [Abstract] [Full Text] [Related]

  • 18. Mutations in EPHB4 cause human venous valve aplasia.
    Lyons O, Walker J, Seet C, Ikram M, Kuchta A, Arnold A, Hernández-Vásquez M, Frye M, Vizcay-Barrena G, Fleck RA, Patel AS, Padayachee S, Mortimer P, Jeffery S, Berland S, Mansour S, Ostergaard P, Makinen T, Modarai B, Saha P, Smith A.
    JCI Insight; 2021 Sep 22; 6(18):. PubMed ID: 34403370
    [Abstract] [Full Text] [Related]

  • 19. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
    Zamora DO, Babra B, Pan Y, Planck SR, Rosenbaum JT.
    Cell Immunol; 2006 Aug 22; 242(2):99-109. PubMed ID: 17123494
    [Abstract] [Full Text] [Related]

  • 20. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells.
    Liu H, Devraj K, Möller K, Liebner S, Hecker M, Korff T.
    Thromb Haemost; 2014 Jul 03; 112(1):151-63. PubMed ID: 24522257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.